Randal J Kirk - Net Worth and Insider Trading

Randal J Kirk Net Worth

The estimated net worth of Randal J Kirk is at least $1.2 Billion dollars as of 2024-07-16. Randal J Kirk is the 10% Owner of Halozyme Therapeutics Inc and owns about 14,092,771 shares of Halozyme Therapeutics Inc (HALO) stock worth over $756 Million. Randal J Kirk is the 10% Owner of Translate Bio Inc and owns about 7,550,669 shares of Translate Bio Inc (TBIO) stock worth over $282 Million. Randal J Kirk is also the Director, 10% Owner of Precigen Inc and owns about 96,757,351 shares of Precigen Inc (PGEN) stock worth over $173 Million. Besides these, Randal J Kirk also holds Fibrocell Science Inc (FCSC) , Alaunos Therapeutics Inc (TCRT) , AquaBounty Technologies Inc (AQB) , Ocugen Inc (OCGN) , Oragenics Inc (OGEN) , Armata Pharmaceuticals Inc (ARMP) , Precipio Inc (PRPO) , Soligenix Inc (SNGX) , Theriva Biologics Inc (TOVX) . Details can be seen in Randal J Kirk's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Randal J Kirk has not made any transactions after 2023-12-28 and currently still holds the listed stock(s).

Transaction Summary of Randal J Kirk

Randal J Kirk Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Randal J Kirk owns 11 companies in total, including Precigen Inc (PGEN) , AquaBounty Technologies Inc (AQB) , and Fibrocell Science Inc (FCSC) among others .

Click here to see the complete history of Randal J Kirk’s form 4 insider trades.

Insider Ownership Summary of Randal J Kirk

Ticker	Comapny	Transaction Date	Type of Owner
PGEN	Precigen Inc	2023-12-28	director & 10 percent owner & Chief Executive Officer
AQB	AquaBounty Technologies Inc	2021-11-23	10 percent owner
FCSC	Fibrocell Science Inc	2019-12-13	10 percent owner
		2019-04-03	10 percent owner
		2019-01-15	10 percent owner
		2013-10-29	director
		2018-08-28	10 percent owner
		2018-08-28	10 percent owner
		2017-05-08	10 percent owner
		2016-12-29	10 percent owner
		2016-06-30	10 percent owner

Randal J Kirk Latest Holdings Summary

Randal J Kirk currently owns a total of 12 stocks. Among these stocks, Randal J Kirk owns 14,092,771 shares of Halozyme Therapeutics Inc (HALO) as of August 28, 2018, with a value of $756 Million and a weighting of 62.13%. Randal J Kirk owns 7,550,669 shares of Translate Bio Inc (TBIO) as of January 6, 2016, with a value of $282 Million and a weighting of 23.17%. Randal J Kirk also owns 96,757,351 shares of Precigen Inc (PGEN) as of December 28, 2023, with a value of $173 Million and a weighting of 14.18%. The other 9 stocks Fibrocell Science Inc (FCSC) , Alaunos Therapeutics Inc (TCRT) , AquaBounty Technologies Inc (AQB) , Ocugen Inc (OCGN) , Oragenics Inc (OGEN) , Armata Pharmaceuticals Inc (ARMP) , Precipio Inc (PRPO) , Soligenix Inc (SNGX) , Theriva Biologics Inc (TOVX) have a combined weighting of 0.52% among all his current holdings.

Latest Holdings of Randal J Kirk

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HALO	Halozyme Therapeutics Inc	2018-08-28	14,092,771	53.68	756,499,947
TBIO	Translate Bio Inc	2016-01-06	7,550,669	37.36	282,092,994
PGEN	Precigen Inc	2023-12-28	96,757,351	1.79	172,711,872
FCSC	Fibrocell Science Inc	2017-12-11	1,653,483	3.00	4,960,449
TCRT	Alaunos Therapeutics Inc	2013-10-29	1,186,460	0.61	729,376
AQB	AquaBounty Technologies Inc	2021-11-23	266,991	1.76	468,569
OCGN	Ocugen Inc	2019-01-15	28,207	1.95	55,004
OGEN	Oragenics Inc	2016-06-30	25,803	1.13	29,206
ARMP	Armata Pharmaceuticals Inc	2016-12-29	10,074	2.88	29,013
PRPO	Precipio Inc	2018-08-28	4,448	4.58	20,372
SNGX	Soligenix Inc	2017-05-08	2,191	7.25	15,874
TOVX	Theriva Biologics Inc	2019-04-03	22,767	0.27	6,229

Holding Weightings of Randal J Kirk

Randal J Kirk Form 4 Trading Tracker

According to the SEC Form 4 filings, Randal J Kirk has made a total of 0 transactions in Halozyme Therapeutics Inc (HALO) over the past 5 years. The most-recent trade in Halozyme Therapeutics Inc is the sale of 644,998 shares on August 28, 2018, which brought Randal J Kirk around $12 Million.

According to the SEC Form 4 filings, Randal J Kirk has made a total of 0 transactions in Translate Bio Inc (TBIO) over the past 5 years. The most-recent trade in Translate Bio Inc is the acquisition of 4,474,825 shares on January 6, 2016, which cost Randal J Kirk around $4 Million.

According to the SEC Form 4 filings, Randal J Kirk has made a total of 7 transactions in Precigen Inc (PGEN) over the past 5 years, including 7 buys and 0 sells. The most-recent trade in Precigen Inc is the acquisition of 96,686 shares on December 28, 2023, which cost Randal J Kirk around $136,327.

More details on Randal J Kirk's insider transactions can be found in the Insider Trading History of Randal J Kirk table.

Insider Trading History of Randal J Kirk

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Randal J Kirk Trading Performance

GuruFocus tracks the stock performance after each of Randal J Kirk's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Randal J Kirk is 9.37%. GuruFocus also compares Randal J Kirk's trading performance to market benchmark return within the same time period. The performance of stocks bought by Randal J Kirk within 3 months outperforms 40 times out of 71 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Randal J Kirk's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Randal J Kirk

Average Return

Average return per transaction

Outperforming Transactions

19 out of 68 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	14.92
Relative Return to S&P 500(%)	13.51

Randal J Kirk Ownership Network

Ownership Network List of Randal J Kirk

No Data

Ownership Network Relation of Randal J Kirk

Randal J Kirk Owned Company Details

What does Precigen Inc do?

Who are the key executives at Precigen Inc?

Randal J Kirk is the director & 10 percent owner & Chief Executive Officer of Precigen Inc. Other key executives at Precigen Inc include director & President and CEO Helen Sabzevari , Chief Operating Officer Rutul R Shah , and Chief Financial Officer Harry Jr. Thomasian .

Precigen Inc (PGEN) Insider Trades Summary

Over the past 18 months, Randal J Kirk made 3 insider transaction in Precigen Inc (PGEN) with a net purchase of 12,025,257. Other recent insider transactions involving Precigen Inc (PGEN) include a net sale of 204,273 shares made by Helen Sabzevari , a net sale of 12,301 shares made by Rutul R Shah , and a net sale of 6,806 shares made by Jeffrey Thomas Perez .

In summary, during the past 3 months, insiders sold 0 shares of Precigen Inc (PGEN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 455,706 shares of Precigen Inc (PGEN) were sold and 13,109,743 shares were bought by its insiders, resulting in a net purchase of 12,654,037 shares.

Precigen Inc (PGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Precigen Inc Insider Transactions

No Available Data

What does AquaBounty Technologies Inc do?

Who are the key executives at AquaBounty Technologies Inc?

Randal J Kirk is the 10 percent owner of AquaBounty Technologies Inc. Other key executives at AquaBounty Technologies Inc include President Melbourne David Francis Jr , director & CEO & Director Sylvia Wulf , and See Remarks David A Frank .

AquaBounty Technologies Inc (AQB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of AquaBounty Technologies Inc (AQB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AquaBounty Technologies Inc (AQB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

AquaBounty Technologies Inc (AQB)'s detailed insider trading history can be found in Insider Trading Tracker table.

AquaBounty Technologies Inc Insider Transactions

No Available Data

What does Fibrocell Science Inc do?

Who are the key executives at Fibrocell Science Inc?

Randal J Kirk is the 10 percent owner of Fibrocell Science Inc. Other key executives at Fibrocell Science Inc include 10 percent owner Intrexon Corp , director & Chairman and CEO David Pernock , and SVP and General Counsel Marino Michael F Iii .

Fibrocell Science Inc (FCSC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Fibrocell Science Inc (FCSC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Fibrocell Science Inc (FCSC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Fibrocell Science Inc (FCSC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Fibrocell Science Inc Insider Transactions

No Available Data

What does Theriva Biologics Inc do?

Who are the key executives at Theriva Biologics Inc?

Randal J Kirk is the 10 percent owner of Theriva Biologics Inc. Other key executives at Theriva Biologics Inc include director & CEO and CFO Steven A Shallcross , Chief Operating Officer Francis Tufaro , and CHIEF MEDICAL OFFICER Joseph A. Sliman .

Theriva Biologics Inc (TOVX) Insider Trades Summary

Over the past 18 months, Randal J Kirk made no insider transaction in Theriva Biologics Inc (TOVX). Other recent insider transactions involving Theriva Biologics Inc (TOVX) include a net purchase of 140,000 shares made by Steven A Shallcross ,

In summary, during the past 3 months, insiders sold 0 shares of Theriva Biologics Inc (TOVX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Theriva Biologics Inc (TOVX) were sold and 140,000 shares were bought by its insiders, resulting in a net purchase of 140,000 shares.

Theriva Biologics Inc (TOVX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Theriva Biologics Inc Insider Transactions

No Available Data

What does Ocugen Inc do?

Who are the key executives at Ocugen Inc?

Randal J Kirk is the 10 percent owner of Ocugen Inc. Other key executives at Ocugen Inc include CFO/CBO Quan Anh Vu , director & Chief Executive Officer Shankar Musunuri , and Chief Scientific Officer Arun Upadhyay .

Ocugen Inc (OCGN) Insider Trades Summary

Over the past 18 months, Randal J Kirk made no insider transaction in Ocugen Inc (OCGN). Other recent insider transactions involving Ocugen Inc (OCGN) include a net sale of 200,000 shares made by Shankar Musunuri , and a net purchase of 200,278 shares made by Junge Zhang .

In summary, during the past 3 months, insiders sold 0 shares of Ocugen Inc (OCGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 200,000 shares of Ocugen Inc (OCGN) were sold and 200,278 shares were bought by its insiders, resulting in a net purchase of 278 shares.

Ocugen Inc (OCGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ocugen Inc Insider Transactions

No Available Data

What does Alaunos Therapeutics Inc do?

Who are the key executives at Alaunos Therapeutics Inc?

Randal J Kirk is the director of Alaunos Therapeutics Inc. Other key executives at Alaunos Therapeutics Inc include director & Chief Executive Officer Boyle Kevin S. Sr. , VP & Finance Michael Wong , and See Remarks Abhishek K Srivastava .

Alaunos Therapeutics Inc (TCRT) Insider Trades Summary

Over the past 18 months, Randal J Kirk made no insider transaction in Alaunos Therapeutics Inc (TCRT). Other recent insider transactions involving Alaunos Therapeutics Inc (TCRT) include a net sale of 68,014 shares made by Boyle Kevin S. Sr. ,

In summary, during the past 3 months, insiders sold 0 shares of Alaunos Therapeutics Inc (TCRT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,534 shares of Alaunos Therapeutics Inc (TCRT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,534 shares.

Alaunos Therapeutics Inc (TCRT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Alaunos Therapeutics Inc Insider Transactions

No Available Data

What does Precipio Inc do?

Who are the key executives at Precipio Inc?

Randal J Kirk is the 10 percent owner of Precipio Inc. Other key executives at Precipio Inc include Chief Operations Officer Ahmed Zaki Sabet , director & Chief Executive Officer Ilan Danieli , and Chief Financial Officer Matthew Gage .

Precipio Inc (PRPO) Insider Trades Summary

Over the past 18 months, Randal J Kirk made no insider transaction in Precipio Inc (PRPO). Other recent insider transactions involving Precipio Inc (PRPO) include a net purchase of 20,000 shares made by Richard A Sandberg ,

In summary, during the past 3 months, insiders sold 0 shares of Precipio Inc (PRPO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Precipio Inc (PRPO) were sold and 1,000 shares were bought by its insiders, resulting in a net purchase of 1,000 shares.

Precipio Inc (PRPO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Precipio Inc Insider Transactions

No Available Data

What does Halozyme Therapeutics Inc do?

Who are the key executives at Halozyme Therapeutics Inc?

Randal J Kirk is the 10 percent owner of Halozyme Therapeutics Inc. Other key executives at Halozyme Therapeutics Inc include SVP & Chief Financial Officer Nicole Labrosse , SVP & Chief Technical Officer Michael J. Labarre , and director & President and CEO Helen Torley .

Halozyme Therapeutics Inc (HALO) Insider Trades Summary

Over the past 18 months, Randal J Kirk made no insider transaction in Halozyme Therapeutics Inc (HALO). Other recent insider transactions involving Halozyme Therapeutics Inc (HALO) include a net sale of 245,862 shares made by Michael J. Labarre , a net sale of 191,061 shares made by Helen Torley , and a net sale of 32,525 shares made by Nicole Labrosse .

In summary, during the past 3 months, insiders sold 100,000 shares of Halozyme Therapeutics Inc (HALO) in total and bought 0 shares, with a net sale of 100,000 shares. During the past 18 months, 529,448 shares of Halozyme Therapeutics Inc (HALO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 529,448 shares.

Halozyme Therapeutics Inc (HALO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Halozyme Therapeutics Inc Insider Transactions

No Available Data

What does Soligenix Inc do?

Who are the key executives at Soligenix Inc?

Randal J Kirk is the 10 percent owner of Soligenix Inc. Other key executives at Soligenix Inc include CMO Richard Straube , director & Chairman & CEO and President Christopher Schaber , and Chief Financial Officer Jonathan L. Guarino .

Soligenix Inc (SNGX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Soligenix Inc (SNGX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Soligenix Inc (SNGX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Soligenix Inc (SNGX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Soligenix Inc Insider Transactions

No Available Data

What does Armata Pharmaceuticals Inc do?

Who are the key executives at Armata Pharmaceuticals Inc?

Randal J Kirk is the 10 percent owner of Armata Pharmaceuticals Inc. Other key executives at Armata Pharmaceuticals Inc include Corporate Controller and PFO Richard Rychlik , director & Chief Executive Officer Deborah Birx , and Chief Financial Officer Julianne Averill .

Armata Pharmaceuticals Inc (ARMP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Armata Pharmaceuticals Inc (ARMP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Armata Pharmaceuticals Inc (ARMP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Armata Pharmaceuticals Inc (ARMP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Armata Pharmaceuticals Inc Insider Transactions

No Available Data

What does Oragenics Inc do?

Who are the key executives at Oragenics Inc?

Randal J Kirk is the 10 percent owner of Oragenics Inc. Other key executives at Oragenics Inc include CFO & Secretary and Treasurer Janet Huffman , director & 10 percent owner Robert C Koski , and CFO & Secretary and Treasurer Michael O'keefe Sullivan .

Oragenics Inc (OGEN) Insider Trades Summary

Over the past 18 months, Randal J Kirk made no insider transaction in Oragenics Inc (OGEN). Other recent insider transactions involving Oragenics Inc (OGEN) include a net sale of 3,500 shares made by Fred Telling ,

In summary, during the past 3 months, insiders sold 0 shares of Oragenics Inc (OGEN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,500 shares of Oragenics Inc (OGEN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,500 shares.

Oragenics Inc (OGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Oragenics Inc Insider Transactions

No Available Data

Randal J Kirk Mailing Address

Above is the net worth, insider trading, and ownership report for Randal J Kirk. You might contact Randal J Kirk via mailing address: 1881 Grove Avenue, Radford Va 24141.

Discussions on Randal J Kirk

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.